On weekend episodes of the podcast, Suhail introduces listeners to tech companies with a potential 50-100% upside over the next twelve months. Today, Suhail talks about a MedTech company listed on the AMEX that has been crushed over the years and is 85% below its all-time high of over $5 a share.

The company develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes primarily in Europe. Its products are an implantable CGM system to measure glucose levels in people with diabetes 24/7 and for a period of up to 90 and 180 days. Listen to the podcast to learn more about the company and why it got Suhail's attention.